Safety and Tolerability Profiles of Anticholinergic Agents Used for the Treatment of Overactive Bladder

ISSN： 0114-5916

Source： Drug Safety, Vol.34, Iss.9, 2011-09, pp. : 733-754

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Improving the Tolerability of Anticholinergic Agents in the Treatment of Overactive Bladder

By Dmochowski Roger

Drug Safety, Vol. 28, Iss. 7, 2005-01 ,pp. : 583-600

Adis International

Access to resources Recommend Favorite

Trospium chloride: an anticholinergic quaternary ammonium compound for the treatment of overactive bladder

By Zinner Norman R

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 8, 2005-07 ,pp. : 1409-1420

Informa Healthcare

Access to resources Recommend Favorite

Effect of Anticholinergic Use for the Treatment of Overactive Bladder on Cognitive Function in Postmenopausal Women

By Geller Elizabeth J.

Clinical Drug Investigation, Vol. 32, Iss. 10, 2012-10 ,pp. : 697-705

Adis International

Access to resources Recommend Favorite

Evidence for the efficacy and safety of tolterodine in the treatment of overactive bladder

By Abrams Paul

Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 10, 2001-10 ,pp. : 1685-1701

Informa Healthcare

Access to resources Recommend Favorite

Twelve-Month Treatment of Overactive Bladder: Efficacy and Tolerability of Tolterodine

By Abrams P.

Drugs & Aging, Vol. 18, Iss. 7, 2001-01 ,pp. : 551-560

Adis International

Access to resources Recommend Favorite